Skip to content
10-K

Annual Report

PREMIER BIOMEDICAL INC

0001654954-20-005676

← back to feed
Filed
May 15, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · May 1, 2020 999.98M sh
Capex FY 2019 · Dec 31, 2019 $4.85K
Capex FY 2019 · Dec 31, 2018 $2.03K
Operating Cash Flow FY 2019 · Dec 31, 2019 −$344.18K
Operating Cash Flow FY 2019 · Dec 31, 2018 −$444.88K
Stockholders Equity FY 2019 · Dec 31, 2019 −$1.83M
Stockholders Equity FY 2019 · Dec 31, 2018 −$2.15M
Stockholders Equity FY 2019 · Dec 31, 2017 −$2.61M
Current Liabilities FY 2019 · Dec 31, 2019 $1.93M
Current Liabilities FY 2019 · Dec 31, 2018 $2.31M
Total Liabilities FY 2019 · Dec 31, 2019 $1.93M
Total Liabilities FY 2019 · Dec 31, 2018 $2.31M
Current Assets FY 2019 · Dec 31, 2019 $93.72K
Current Assets FY 2019 · Dec 31, 2018 $159.79K
Total Assets FY 2019 · Dec 31, 2019 $100.94K
Total Assets FY 2019 · Dec 31, 2018 $164.99K
Sga Expense FY 2019 · Dec 31, 2019 $200.64K
Sga Expense FY 2019 · Dec 31, 2018 $189.29K
Net Income FY 2019 · Dec 31, 2019 −$374.47K
Net Income FY 2019 · Dec 31, 2018 −$398.89K
Operating Income FY 2019 · Dec 31, 2019 −$326.74K
Operating Income FY 2019 · Dec 31, 2018 −$692.84K
Gross Profit FY 2019 · Dec 31, 2019 $1.42K
Gross Profit FY 2019 · Dec 31, 2018 −$73.93K
Cost Of Revenue FY 2019 · Dec 31, 2019 $12.86K
Cost Of Revenue FY 2019 · Dec 31, 2018 $113.73K
Revenue FY 2019 · Dec 31, 2019 $14.28K
Revenue FY 2019 · Dec 31, 2018 $39.8K
Cash And Equivalents FY 2019 · Dec 31, 2018 $86.83K
Cash And Equivalents FY 2019 · Dec 31, 2017 $83.7K